North Macedonia – Angiography supplies – Procurement of medical dispensable material for Interventional Cardiology – coronary stents.
Issued by Public Health Institution Specialized Hospital for prevention, treatment and rehabilitation of cardiovascular diseases – Ohrid · via TED — Tenders Electronic Daily (EU)
- Published
- 5 Sept 2026
- Closes
- 30 Sept 2026, 23:59 UTC
- Value
- EUR 49,430
- Reference
- 605445-2026
- Location
- North Macedonia
- Sector
- Healthcare & Pharma
- Type
- goods
Details
The subject of the agreement consists of 11 separate parts, including:
Lots Lot 1 — A coronary stent made of a chromium alloy (cobalt or platinum) with a continuous sinusoidal configuration and a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR (estimated 49430) Lot 2 — A coronary stent made of a chromium alloy (cobalt or platinum) with a bioabsorbable polymer and hybrid coating with an active component of an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR and a passive component that lowers the thrombogenicity (estimated 25609) Lot 3 — A coronary stent made of a chromium and cobalt alloy with an abluminal biodegradable polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR. Diameter 2.0-4.5mm, length 9-50mm. (estimated 106991) Lot 4 — A coronary stent made of a chromium and cobalt alloy with a hybrid cell design and a low stent crossing profile ≤ 0.041” (it refers to a stent with a diameter of up to 3mm), with a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR (estimated 99186) Lot 5 — A coronary stent made of multiple cobalt alloys (chromium or nickel) designed for large post-dilatation expansions ≥ 5.5mm in large blood vessels, with a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR (estimated 57560) Lot 6 — A coronary stent made of a chromium and platinum alloy with a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR (estimated 20487) Lot 7 — A coronary stent made of a chromium and platinum alloy with an abluminal biodegradable polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR, with a diameter from 2.25 to 5mm, length from 8 to 48mm, compatible with 5F guiding catheter for all dimensions (estimated 12439) Lot 8 — A coronary stent made of a chromium and cobalt alloy, with a polymer and carrier free technology, coated with an immunosuppressant on the abluminal surface that stops the cell cycle progression by inhibiting the m-TOR. - time of delivery of the medicine shall be 30 days or less, - effective length of the shaft 142cm+/3cm, - shaft diameter: proximal 2.1F or less, distal 2.6F or less - struts thickn (estimated 14146): A coronary stent made of a chromium and cobalt alloy, with a polymer and carrier free technology, coated with an immunosuppressant on the abluminal surface that stops the cell cycle progression by inhibiting the m-TOR. - time of delivery of the medicine shall be 30 days or less, - effective length of the shaft 142cm+/3cm, - shaft diameter: proximal 2.1F or less, distal 2.6F or less - struts thickness: 85 micrometers or less, for a stent with a diameter of up to 3.0mm, - stent length: 9-36mm or longer, - stent diameter: 2.25-4.0mm or more, - maximum expansion of the stent diameter 5.95mm for stents with a diameter of 3.5mm and 4mm. Lot 9 — A coronary stent made of a chromium and cobalt alloy, with a biodegradable polymer (PLA) technology, coated with an immunosuppressant on the abluminal surface that stops the cell cycle progression by inhibiting the m-TOR. - time of delivery of the medicine and polymer absorption shall be synchronized, for 9 months or less, -Lesion entry profile: 0.017“ or less, - effective length of the shaft 142 (estimated 32520): A coronary stent made of a chromium and cobalt alloy, with a biodegradable polymer (PLA) technology, coated with an immunosuppressant on the abluminal surface that stops the cell cycle progression by inhibiting the m-TOR. - time of delivery of the medicine and polymer absorption shall be synchronized, for 9 months or less, -Lesion entry profile: 0.017“ or less, - effective length of the shaft 142cm+/-3cm, - shaft diameter: proximal 2.0F or less, distal 2.6F or less - struts thickness: 85 micrometers or less, for a stent with a diameter of up to 3.0mm, - stent length: 9-36mm or longer, - stent diameter: 2.25-4.0mm or more, -maximum expansion of the stent diameter 5.95mm for stents with a diameter of 3.5mm and 4mm. Lot 10 — A coronary stent made of cobalt-chromium alloy, multi-link, featuring a Peak-to-Valley stent design for treatment of tapered (conically narrowed) coronary lesions with small and large diameters, coated with a permanent polymer and the cytostatic everolimus (DES). Strut thickness: 81 micrometers. Diameter range: 2 to 5 mm, length from 8 to 48 mm, and expandable up to 5.75 mm for diameters of 3.5 to (estimated 14878): A coronary stent made of cobalt-chromium alloy, multi-link, featuring a Peak-to-Valley stent design for treatment of tapered (conically narrowed) coronary lesions with small and large diameters, coated with a permanent polymer and the cytostatic everolimus (DES). Strut thickness: 81 micrometers. Diameter range: 2 to 5 mm, length from 8 to 48 mm, and expandable up to 5.75 mm for diameters of 3.5 to 5.0 mm, and up to 3.75 mm for diameters of 2.0 to 3.25 mm, without shortening Lot 11 — A coronary cobalt-chromium stent with a permanent polymer, elastomer, featuring 4 markers, two positioned proximally and two distally, with a WZ stent design and a vessel wall imprint of 40 μm for the Z strut and 72 μm for the W strut with an exceptional radiopacity, with a metal spring tip at the catheter, enabling easier navigation through the blood vessels and improved visibility, coated with a (estimated 18536): A coronary cobalt-chromium stent with a permanent polymer, elastomer, featuring 4 markers, two positioned proximally and two distally, with a WZ stent design and a vessel wall imprint of 40 μm for the Z strut and 72 μm for the W strut with an exceptional radiopacity, with a metal spring tip at the catheter, enabling easier navigation through the blood vessels and improved visibility, coated with a drug from the LIMUS family, with diameters ranging from 2.25 to 4.00 mm and length from 8 to 44 mm, or equivalent
Buyer: Public Health Institution Specialized Hospital for prevention, treatment and rehabilitation of cardiovascular diseases – Ohrid
Buyer country: MKD
Procedure: open
CPV code: 33111710
Full notice, tender documents and how to bid are on the official TED page (link above).
Context for bidders
There are 7 open Healthcare & Pharma tenders in North Macedonia. This one closes in 26 days.
Similar Healthcare & Pharma tenders
- North Macedonia – X-ray devices – Procurement of a digital X-ray machine· closes 29 Sept
- North Macedonia – Medical equipments, pharmaceuticals and personal care products – Мedicines· closes 29 Sept
- North Macedonia – Medical equipments, pharmaceuticals and personal care products – Medical Consumables for Interventional Procedures – Introducer Sheaths, Guidewires, Catheters and Other Medical Consumables· closes 22 Sept
- North Macedonia – Endoscopy, endosurgery devices – Endoscopic consumables· closes 23 Sept
- North Macedonia – Medical equipments, pharmaceuticals and personal care products – Incorporated materials· closes 19 Sept
Documents
- TED-official-notice-605445-2026.pdfDownload (pdf)
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- RFP - Selection of an Agency for Microsoft 365 licenses and implementation and supportJhpiego · India
- Ward No 19 Mohalla Nakhasa mein Riyaz Bhai ke makan se Noor Medical Store tak marg ka premix ke sath naveenikaran ka karya.Directorate of Local Bodies UP · Nagar Palika Parishad Sambhal Sambhal · India
- Purchase of Tranquilizer Medicines for wildlifeMP Forest Department · Panna Tiger Reserve Panna · DD Panna Tiger Reserve · India
- Supply and installation of new main Pannel with Fire supression system to main building and eye hospital at DHH khordha Buildings.EIC-CIVIL · SERNB-CIRCLE-KHURDA · EERNB DIVN KHURDA · India
- Scanning av gamle Narvik sykehusNordland fylkeskommune · Norway
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →